Overview

Ingestible Smart Pills Market is poised to value over USD 1.7 billion by 2028 end at a CAGR of over 5.7% during the forecast period 2022 to 2028.

Small implanted electronic components, such as sensors, cameras, patches, and trackers, make up smart pills. When taken, these pills can provide a comprehensive diagnostic assessment of the gastrointestinal tract. Smart tablets provide various advantages, including noninvasive disease diagnostics, patient adherence, and satisfaction. The population that has the greatest need for home health care services has the most trouble utilising these devices. As a result, smart pill designers and developers are working to improve the usability and accessibility of these devices so that they can provide vital health information to users. The devices are designed in such a way that even a layperson can easily interpret the data. Most companies in this sector offer suitable software that collects data over time and provides vital information on patient health as well as lifestyle tips. Through the Bluetooth component, these smart pill devices can also be connected to cellphones. The growing geriatric population and the rapid development of healthcare facilities are expected to drive the worldwide ingestible smart pill market forward in the coming years. Innovations and technological advancements in this industry are also expected to contribute to the overall market's growth. Furthermore, patients' willingness to spend more on healthcare facilities fuels the growth of the Ingestible Smart Pills market.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Ingestible Smart Pills Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Ingestible Smart Pills Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Ingestible Smart Pills Market:
• BodyCap Medical
• Given Imaging Ltd.
• Olympus Corporation
• Proteus Digital Health, Inc.
• CapsoVision, Inc.
• Chongqing Jinshan Science and Component (Group) Co., Ltd.
• Medimetrics
• IntroMedic Co., Ltd.
• Check-Cap Ltd.
• Boston Scientific Corporation
• HQ Inc.
(Note: The list of the major players will be updated with the latest market scenario and trends)

Ingestible Smart Pills Market Segmentation:
By Component
• Smart Pills
 o Patient Monitoring
 o Capsule Endoscopy
   o Small Bowel Endoscopy
   o Esophagus Endoscopy
   o Colon Endoscopy
 o Workstation
By Application
• Imaging
• Monitoring
By End User
• Hospitals
• Clinics
• Research Institutes
• Home Healthcare
By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Ingestible Smart Pills Market By Component, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
  1.1. Objectives of the Study
  1.2. Market Definition
  1.3. Market Scope
       1.3.1. Years Considered for the Study
       1.3.2. Market Covered
  1.4. Currency
  1.5. Limitations
  1.6. Stakeholders

2. Research Methodology
  2.1. Research Data
       2.1.1. Secondary Data
              2.1.1.1. Key Data from Secondary Sources
       2.1.2. Primary Data
              2.1.2.1. Key Data from Primary Sources
  2.2. Market Size Estimation
  2.3. Market Breakdown and Data Triangulation
  2.4. Assumptions for the Study  

3. Executive Summary
  3.1. Market Outlook
  3.2. Segment Outlook
  3.3. Competitive Insights

4. Ingestible Smart Pills Market Variables, Trends & Scope
  4.1. Market Lineage Outlook
  4.2. Penetration and Growth Prospect Mapping
  4.3. Industry Value Chain Analysis
  4.4. Cost Analysis Breakdown
  4.5. Technology Overview
  4.6. Regulatory Framework
       4.6.1. Reimbursement Framework
       4.6.2. Standards and Compliances

5. Market Overview
  5.1. Market Dynamics
       5.1.1. Market Driver Analysis
              5.1.1.1. Increasing focus of Ingestible Smart Pills Market Companies on Brand Protection
              5.1.1.2. Untapped Opportunities in Emerging Regions
       5.1.2. Market Restraint Analysis
              5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
       5.1.3. Industry Challenges
              5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Ingestible Smart Pills Market Analysis Tools
  6.1. Industry Analysis - Porter’s
       6.1.1. Supplier Power
       6.1.2. Buyer Power
       6.1.3. Substitution Threat
       6.1.4. Threat from New Entrants
       6.1.5. Competitive Rivalry
  6.2. Pestel Analysis
       6.2.1. Political Landscape
       6.2.2. Environmental Landscape
       6.2.3. Social Landscape
       6.2.4. Technology Landscape
       6.2.5. Legal Landscape
  6.3. Major Deals And Strategic Alliances Analysis
       6.3.1. Joint Ventures
       6.3.2. Mergers and Acquisitions
       6.3.3. Licensing and Partnership
       6.3.4. Technology Collaborations
       6.3.5. Strategic Divestments
  6.4. Market Entry Strategies
  6.5. Case Studies

7. Ingestible Smart Pills Market, By Component Historical Analysis and Forecast 2022-2028 (USD Million)
  7.1. Smart Pills
       7.1.1. Patient Monitoring
       7.1.2. Capsule Endoscopy
              7.1.2.1. Small Bowel Endoscopy
              7.1.2.2. Esophagus Endoscopy
              7.1.2.3. Colon Endoscopy
       7.1.3. Workstation

8. Ingestible Smart Pills Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
  8.1. Imaging
  8.2. Monitoring

9. Ingestible Smart Pills Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)  
  9.1. Hospitals
  9.2. Clinics
  9.3. Research Institutes
  9.4. Home Healthcare

10. North America Ingestible Smart Pills Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   10.1. Introduction
   10.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         10.2.1. U.S.A
         10.2.2. Canada
         10.2.3. Mexico
   10.3. Market Size (USD Million) Forecast for North America 2022-2028

11. Latin America Ingestible Smart Pills Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   11.1. Introduction
   11.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         11.2.1. Brazil
         11.2.2. Venezuela
         11.2.3. Argentina
         11.2.4. Rest of Latin America
   11.3. Market Size (USD Million) Forecast for Latin America 2022-2028

12. Europe Ingestible Smart Pills Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   12.1. Introduction
   12.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         12.2.1. Germany
         12.2.2. U.K        
         12.2.3. France
         12.2.4. Italy
         12.2.5. Spain
         12.2.6. Russia
         12.2.7. Poland
         12.2.8. Rest of Europe
   12.3. Market Size (USD Million) Forecast for Europe 2022-2028

13. Asia Pacific Ingestible Smart Pills Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   13.1. Introduction
   13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         13.2.1. Japan
         13.2.2. China
         13.2.3. India
         13.2.4. Australia and New Zealand
         13.2.5. ASEAN
         13.2.6. Rest of Asia Pacific
   13.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

14. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
   14.1. Introduction
   14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         14.2.1. GCC
         14.2.2. Israel
         14.2.3. South Africa
         14.2.4. Rest of MEA
   14.3. Market Size (USD Million) Forecast for MEA 2022-2028

15. Market Share Analysis and Competitive Landscape  
   15.1. Global Landscape - Key Players, Revenue and Presence
   15.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
   15.3. Global Emerging Companies
   15.4. North America - Market Share Analysis and Key Regional Players
   15.5. Europe - Market Share Analysis and Key Regional Players
   15.6. Asia Pacific - Market Share Analysis and Key Regional Players
   15.7. Global Key Player - Growth Matrix

16. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
   16.1. BodyCap Medical
         16.1.1. Company Overview
         16.1.2. Product Portfolio
         16.1.3. SWOT Analysis
         16.1.4. Financial Overview
         16.1.5. Strategic Overview
   16.2. Given Imaging Ltd.
         16.2.1. Company Overview
         16.2.2. Product Portfolio
         16.2.3. SWOT Analysis
         16.2.4. Financial Overview
         16.2.5. Strategic Overview
   16.3. Olympus Corporation
         16.3.1. Company Overview
         16.3.2. Product Portfolio
         16.3.3. SWOT Analysis
         16.3.4. Financial Overview
         16.3.5. Strategic Overview
   16.4. Proteus Digital Health, Inc.
         16.4.1. Company Overview
         16.4.2. Product Portfolio
         16.4.3. SWOT Analysis
         16.4.4. Financial Overview
         16.4.5. Strategic Overview
   16.5. CapsoVision, Inc.
         16.5.1. Company Overview
         16.5.2. Product Portfolio
         16.5.3. SWOT Analysis
         16.5.4. Financial Overview
         16.5.5. Strategic Overview          
   16.6. Chongqing Jinshan Science and Component (Group) Co., Ltd.
         16.6.1. Company Overview
         16.6.2. Product Portfolio
         16.6.3. SWOT Analysis
         16.6.4. Financial Overview
         16.6.5. Strategic Overview    
   16.7. Medimetrics
         16.7.1. Company Overview
         16.7.2. Product Portfolio
         16.7.3. SWOT Analysis
         16.7.4. Financial Overview
         16.7.5. Strategic Overview
   16.8. IntroMedic Co., Ltd.
         16.8.1. Company Overview
         16.8.2. Product Portfolio
         16.8.3. SWOT Analysis
         16.8.4. Financial Overview
         16.8.5. Strategic Overview
   16.9. Check-Cap Ltd.
         16.9.1. Company Overview
         16.9.2. Product Portfolio
         16.9.3. SWOT Analysis
         16.9.4. Financial Overview
         16.9.5. Strategic Overview
   16.10.Boston Scientific Corporation
         16.10.1. Company Overview
         16.10.2. Product Portfolio
         16.10.3. SWOT Analysis
         16.10.4. Financial Overview
         16.10.5. Strategic Overview
   16.11.HQ Inc.
         16.11.1. Company Overview
         16.11.2. Product Portfolio
         16.11.3. SWOT Analysis
         16.11.4. Financial Overview
         16.11.5. Strategic Overview          

17. Pre and Post COVID-19 Impact
   17.1. Positive influence on the healthcare industry
   17.2. The financial disruption of the manufacturing sector
   17.3. Impact of COVID-19 on emerging companies
   17.4. Significant mandates in the regulations initiated by healthcare administrations
   17.5. The overall economic slowdown of the developing and developed nations

18. FutureWise SME Key Takeaway Points for Client

Tables

Figures